Agios Pharmaceuticals, Inc.
mitapivat
thalassemia
Resolved
128days ago
Approval decision · Mar 1, 2026
What's at stake
A final FDA approval decision on mitapivat for thalassemia is expected Mar 1, 2026.
Primary source
· SEC 8-K
verified 15h ago
“With this approval, PYRUKYND becomes the only medicine approved in the UAE for this broad patient population.”